S6736 — Relates to requiring Medicaid to cover a wearable medical device to treat certain forms of cancer
Last action — In Assembly Committee
-
1Introduced
-
2In Committee
-
3Passed Senate
-
4Passed Assembly
-
5To Executive
-
6Enacted
This bill has been introduced in the Senate. Introduced March 21, 2025. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
In plain language
The bill requires Medicaid to cover a wearable device for treating certain cancers.
This legislation mandates that Medicaid provide coverage for a specific wearable medical device designed to treat glioblastoma and other cancers. The device delivers low-intensity electric fields to the tumor site, based on medical and scientific recommendations.
What this means for you
- Families: Families of patients with glioblastoma and similar cancers could access new treatment options covered by Medicaid.
- Healthcare: This means healthcare providers will need to incorporate this device into treatment plans for eligible cancer patients under Medicaid.
Summary
Requires Medicaid to cover a wearable medical device that uses low-intensity, alternating electric fields delivered to the tumor site to treat glioblastoma and other cancers as recommended by medical and scientific evidence.
Bill Text
- Full text View text Current
Action History
-
REFERRED TO HEALTH
-
DELIVERED TO ASSEMBLY
-
PASSED SENATE
-
ORDERED TO THIRD READING CAL.1714
-
COMMITTEE DISCHARGED AND COMMITTED TO RULES
-
REFERRED TO HEALTH
-
RETURNED TO SENATE
-
DIED IN ASSEMBLY
-
REFERRED TO HEALTH
-
DELIVERED TO ASSEMBLY
-
PASSED SENATE
-
ORDERED TO THIRD READING CAL.1699
-
COMMITTEE DISCHARGED AND COMMITTED TO RULES
-
REPORTED AND COMMITTED TO FINANCE
-
PRINT NUMBER 6736A
-
AMEND AND RECOMMIT TO HEALTH
-
REFERRED TO HEALTH
Sponsors
- Patricia Fahy · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 218 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (218)
218 members have not signed on to this bill.
Show all 218 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does S6736 do?
- Requires Medicaid to cover a wearable medical device that uses low-intensity, alternating electric fields delivered to the tumor site to treat glioblastoma and other cancers as recommended by medical and scientific evidence.
- Who sponsors S6736?
- S6736 is sponsored by Patricia Fahy.
- What is the current status of S6736?
- This bill has been introduced in the Senate. Introduced March 21, 2025. It must pass committee before a floor vote.
- Where can I track S6736?
- Track S6736 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on S6736
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of S6736
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →